DiStasio S - Search Results

1

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL. Psyrri A, et al. Among authors: distasio s. J Clin Oncol. 2004 Aug 1;22(15):3061-9. doi: 10.1200/JCO.2004.01.108. J Clin Oncol. 2004. PMID: 15284256 Clinical Trial.

2

Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer.

Murren JR, Peccerillo K, DiStasio SA, Li X, Leffert JJ, Pizzorno G, Burtness BA, McKeon A, Cheng Y. Murren JR, et al. Among authors: distasio sa. Cancer Chemother Pharmacol. 2000;46(1):43-50. doi: 10.1007/s002800000115. Cancer Chemother Pharmacol. 2000. PMID: 10912577 Clinical Trial.

3

Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting.

Burtness B, Windsor S, Holston B, DiStasio S, Staugaard-Hahn C, Abrantes J, Kneuper-Hall R, Farber L, Orell J, Bober-Sorcinelli K, Haffty BG, Reiss M. Burtness B, et al. Among authors: distasio s. Cancer J Sci Am. 1999 Jul-Aug;5(4):224-9. Cancer J Sci Am. 1999. PMID: 10439168 Clinical Trial.

4

Phase I study of perillyl alcohol in patients with refractory malignancies.

Murren JR, Pizzorno G, DiStasio SA, McKeon A, Peccerillo K, Gollerkari A, McMurray W, Burtness BA, Rutherford T, Li X, Ho PT, Sartorelli A. Murren JR, et al. Among authors: distasio sa. Cancer Biol Ther. 2002 Mar-Apr;1(2):130-5. doi: 10.4161/cbt.57. Cancer Biol Ther. 2002. PMID: 12170772 Clinical Trial.

5

Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphoma.

Argiris A, Heald P, Kuzel T, Foss FM, DiStasio S, Cooper DL, Arbuck S, Murren JR. Argiris A, et al. Among authors: distasio s. Invest New Drugs. 2001;19(4):321-6. doi: 10.1023/a:1010613912335. Invest New Drugs. 2001. PMID: 11561692 Clinical Trial.

6

Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies.

Murren JR, DiStasio SA, Lorico A, McKeon A, Zuhowski EG, Egorin MJ, Sartorelli AC, Rappa G. Murren JR, et al. Among authors: distasio sa. Cancer J. 2000 Jul-Aug;6(4):256-65. Cancer J. 2000. PMID: 11038146 Clinical Trial.

7

Managing bleeding in ulcerating breast lesions.

DiStasio SA. DiStasio SA. Oncol Nurs Forum. 1992 May;19(4):664. Oncol Nurs Forum. 1992. PMID: 1603680 No abstract available.

8

Brachial plexopathy after treatment for breast cancer.

Distasio SA, Salner AL, Brant JM, Fischberg D, Manfredi P. Distasio SA, et al. Cancer Pract. 2000 May-Jun;8(3):110-3. doi: 10.1046/j.1523-5394.2000.83003.x. Cancer Pract. 2000. PMID: 11898134 No abstract available.

9

Integrating yoga into cancer care.

DiStasio SA. DiStasio SA. Clin J Oncol Nurs. 2008 Feb;12(1):125-30. doi: 10.1188/08.CJON.125-130. Clin J Oncol Nurs. 2008. PMID: 18258582 Review.

10

A results-driven risk management program: one surgical group's success story.

Cohen J, Orlando R 3rd, Kelly K, Distasio S. Cohen J, et al. Among authors: distasio s. Physician Exec. 2013 Jan-Feb;39(1):44-9. Physician Exec. 2013. PMID: 23437756 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page